Cargando…
Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562319/ https://www.ncbi.nlm.nih.gov/pubmed/36645770 http://dx.doi.org/10.1136/bmjpo-2022-001661 |
_version_ | 1784808145579671552 |
---|---|
author | Tack, Bieke Ravinetto, Raffaella Allegaert, Karel |
author_facet | Tack, Bieke Ravinetto, Raffaella Allegaert, Karel |
author_sort | Tack, Bieke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9562319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-95623192022-10-15 Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? Tack, Bieke Ravinetto, Raffaella Allegaert, Karel BMJ Paediatr Open Editorial BMJ Publishing Group 2022-10-12 /pmc/articles/PMC9562319/ /pubmed/36645770 http://dx.doi.org/10.1136/bmjpo-2022-001661 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Editorial Tack, Bieke Ravinetto, Raffaella Allegaert, Karel Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
title | Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
title_full | Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
title_fullStr | Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
title_full_unstemmed | Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
title_short | Collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
title_sort | collaborative partnerships as a solution for poor access to essential antimicrobial medicines: what can we learn from the chlorhexidine gel example? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562319/ https://www.ncbi.nlm.nih.gov/pubmed/36645770 http://dx.doi.org/10.1136/bmjpo-2022-001661 |
work_keys_str_mv | AT tackbieke collaborativepartnershipsasasolutionforpooraccesstoessentialantimicrobialmedicineswhatcanwelearnfromthechlorhexidinegelexample AT ravinettoraffaella collaborativepartnershipsasasolutionforpooraccesstoessentialantimicrobialmedicineswhatcanwelearnfromthechlorhexidinegelexample AT allegaertkarel collaborativepartnershipsasasolutionforpooraccesstoessentialantimicrobialmedicineswhatcanwelearnfromthechlorhexidinegelexample |